(JXN) Jackson Financial - Overview
Sector: Financial Services | Industry: Insurance - Life | Exchange: NYSE (USA) | Market Cap: 7.663m USD | Total Return: 36.2% in 12m
Avg Turnover: 60.4M
EPS Trend: 86.5%
Qual. Beats: -1
Rev. Trend: 84.9%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Jackson Financial Inc. (JXN) is a Lansing, Michigan-based financial services provider specializing in retirement income and savings products for the U.S. retail market. The company operates through three primary segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks. Its core offerings include variable, fixed, and registered index-linked annuities, alongside traditional guaranteed investment contracts and legacy life insurance products.
The company utilizes a broad distribution network encompassing independent broker-dealers, wirehouses, banks, and registered investment advisors. In the life and annuity sector, firms like Jackson Financial generate revenue primarily through investment spreads-the difference between the income earned on their general account assets and the interest credited to policyholders-and fee-based income from variable products. This business model is highly sensitive to interest rate environments and equity market volatility, which influence both product demand and hedging costs.
For a more detailed analysis of the companys valuation metrics, consider reviewing the data available on ValueRay.
- Variable annuity sales volume driven by equity market performance and investor sentiment
- Interest rate fluctuations impact hedging costs and statutory capital requirement levels
- Registered index-linked annuity adoption accelerates retail segment revenue growth
- Capital return programs including dividends and buybacks influence shareholder value
- Asset management fees fluctuate based on total assets under management volatility
| Net Income: -373.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.29 > 1.0 |
| NWC/Revenue: 1.01k% < 20% (prev 704.1%; Δ 301.1% < -1%) |
| CFO/TA 0.02 > 3% & CFO 5.21b > Net Income -373.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (69.7m) vs 12m ago -5.11% < -2% |
| Gross Margin: 83.44% > 18% (prev 0.20%; Δ 8.32k% > 0.5%) |
| Asset Turnover: 1.76% > 50% (prev 2.19%; Δ -0.43% > 0%) |
| Interest Coverage Ratio: -4.97 > 6 (EBITDA TTM -497.0m / Interest Expense TTM 100.0m) |
| A: 0.17 (Total Current Assets 74.5b - Total Current Liabilities 15.6b) / Total Assets 340b |
| B: 0.02 (Retained Earnings 6.97b / Total Assets 340b) |
| C: -0.00 (EBIT TTM -497.0m / Avg Total Assets 333b) |
| D: 0.01 (Book Value of Equity 4.24b / Total Liabilities 330b) |
| Altman-Z'' = 1.21 = BB |
| DSRI: 1.11 (Receivables 19.7b/21.7b, Revenue 5.86b/7.17b) |
| GMI: 0.24 (GM 83.44% / 20.43%) |
| AQI: 0.99 (AQ_t 0.78 / AQ_t-1 0.79) |
| SGI: 0.82 (Revenue 5.86b / 7.17b) |
| TATA: -0.02 (NI -373.0m - CFO 5.21b) / TA 340b) |
| Beneish M = -3.78 (Cap -4..+1) = AAA |
As of May 24, 2026, the stock is trading at USD 108.20 with a total of 391,605 shares traded.
Over the past week, the price has changed by -2.62%,
over one month by -4.54%,
over three months by -1.85% and
over the past year by +36.23%.
Jackson Financial has received a consensus analysts rating of 2.80. Therefore, it is recommended to hold JXN.
- StrongBuy: 0
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 122 | 12.8% |
P/B = 0.8414
Revenue TTM = 5.86b USD
EBIT TTM = -497.0m USD
EBITDA TTM = -497.0m USD
Long Term Debt = 4.57b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 4.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -50.3b USD (calculated: Debt 4.57b - CCE 54.8b)
Enterprise Value = 7.66b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = -4.97 (Ebit TTM -497.0m / Interest Expense TTM 100.0m)
EV/FCF = 1.47x (Enterprise Value 7.66b / FCF TTM 5.21b)
FCF Yield = 67.98% (FCF TTM 5.21b / Enterprise Value 7.66b)
FCF Margin = 88.86% (FCF TTM 5.21b / Revenue TTM 5.86b)
Net Margin = -6.36% (Net Income TTM -373.0m / Revenue TTM 5.86b)
Gross Margin = 83.44% ((Revenue TTM 5.86b - Cost of Revenue TTM 971.0m) / Revenue TTM)
Gross Margin QoQ = 22.09% (prev none%)
Tobins Q-Ratio = 0.02 (Enterprise Value 7.66b / Total Assets 340b)
Interest Expense / Debt = 2.19% (Interest Expense 100.0m / Debt 4.57b)
Taxrate = 21.0% (US default 21%)
NOPAT = -392.6m (EBIT -497.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.78 (Total Current Assets 74.5b / Total Current Liabilities 15.6b)
Debt / Equity = 0.48 (Debt 4.57b / totalStockholderEquity, last quarter 9.50b)
Debt / EBITDA = 101.1 (negative EBITDA) (Net Debt -50.3b / EBITDA -497.0m)
Debt / FCF = -9.65 (Net Debt -50.3b / FCF TTM 5.21b)
Total Stockholder Equity = 10.0b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.11% (Net Income -373.0m / Total Assets 340b)
RoE = -3.73% (Net Income TTM -373.0m / Total Stockholder Equity 10.0b)
RoCE = -3.41% (EBIT -497.0m / Capital Employed (Equity 10.0b + L.T.Debt 4.57b))
RoIC = -0.12% (negative operating profit) (NOPAT -392.6m / Invested Capital 324b)
WACC = 7.50% (E(7.66b)/V(12.2b) * Re(10.94%) + D(4.57b)/V(12.2b) * Rd(2.19%) * (1-Tc(0.21)))
Discount Rate = 10.94% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.88 | Cagr: -5.89%
[DCF] Terminal Value 73.52% ; FCFF base≈5.51b ; Y1≈4.94b ; Y5≈4.18b
[DCF] Fair Price = 1.68k (EV 66.8b - Net Debt -50.3b = Equity 117b / Shares 69.7m; r=8.35% [WACC [floored]]; 5y FCF grow -12.62% → 2.50% )
EPS Correlation: 86.49 | EPS CAGR: 18.97% | SUE: -0.91 | # QB: -1
Revenue Correlation: 84.93 | Revenue CAGR: 51.30% | SUE: 0.57 | # QB: 0
EPS current Quarter (2026-06-30): EPS=5.47 | Chg30d=-7.21% | Revisions=-20% | Analysts=1
EPS next Quarter (2026-09-30): EPS=5.65 | Chg30d=-5.69% | Revisions=-20% | Analysts=1
EPS current Year (2026-12-31): EPS=21.85 | Chg30d=-10.32% | Revisions=-20% | GrowthEPS=-3.6% | GrowthRev=+15.3%
EPS next Year (2027-12-31): EPS=26.02 | Chg30d=-3.72% | Revisions=-50% | GrowthEPS=+19.1% | GrowthRev=+3.5%
[Analyst] Revisions Ratio: -50%